Novartis AG (NVS)
98.91
+1.80
(+1.85%)
USD |
NYSE |
Jun 02, 16:00
99.00
+0.09
(+0.09%)
After-Hours: 20:00
Novartis Price: 98.91 for June 2, 2023
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Jun 02, 2023 | 98.11 | 98.93 | 97.89 | 98.91 | 3.737M |
Jun 01, 2023 | 97.01 | 97.16 | 96.56 | 97.11 | 2.536M |
May 31, 2023 | 96.19 | 96.49 | 95.34 | 96.25 | 3.608M |
May 30, 2023 | 96.80 | 97.10 | 96.10 | 96.55 | 1.811M |
May 26, 2023 | 98.19 | 98.83 | 97.73 | 97.86 | 2.946M |
May 25, 2023 | 98.66 | 98.66 | 97.35 | 97.78 | 3.450M |
May 24, 2023 | 100.19 | 100.23 | 99.70 | 100.03 | 1.458M |
May 23, 2023 | 101.49 | 101.50 | 100.21 | 100.25 | 2.214M |
May 22, 2023 | 101.46 | 102.00 | 100.64 | 100.74 | 1.819M |
May 19, 2023 | 99.99 | 101.00 | 99.98 | 100.81 | 1.530M |
May 18, 2023 | 100.72 | 101.14 | 99.56 | 100.35 | 1.980M |
May 17, 2023 | 102.29 | 102.29 | 100.89 | 101.22 | 2.616M |
May 16, 2023 | 103.16 | 103.23 | 102.77 | 102.81 | 1.417M |
May 15, 2023 | 103.35 | 103.48 | 102.70 | 103.12 | 1.453M |
May 12, 2023 | 103.09 | 103.80 | 102.97 | 103.14 | 1.783M |
May 11, 2023 | 103.22 | 103.57 | 102.78 | 103.42 | 1.361M |
May 10, 2023 | 103.62 | 103.89 | 102.86 | 103.63 | 1.654M |
May 09, 2023 | 104.51 | 104.92 | 104.30 | 104.70 | 1.255M |
May 08, 2023 | 104.60 | 105.35 | 104.39 | 104.91 | 1.189M |
May 05, 2023 | 103.81 | 104.88 | 103.40 | 104.72 | 937252.0 |
May 04, 2023 | 104.47 | 104.86 | 103.94 | 104.62 | 1.408M |
May 03, 2023 | 104.11 | 104.82 | 103.73 | 104.45 | 1.569M |
May 02, 2023 | 101.96 | 103.68 | 101.91 | 103.54 | 2.370M |
May 01, 2023 | 102.75 | 102.98 | 102.39 | 102.54 | 1.018M |
Apr 28, 2023 | 101.84 | 102.75 | 101.55 | 102.57 | 1.892M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
70.67
Minimum
Mar 23 2020
104.91
Maximum
May 08 2023
86.71
Average
86.68
Median
Jun 01 2020
Price Benchmarks
Amgen Inc | 218.07 |
AstraZeneca PLC | 72.59 |
Biogen Inc | 300.20 |
Johnson & Johnson | 156.97 |
Novo Nordisk A/S | 157.14 |
Price Related Metrics
PE Ratio | 30.43 |
PS Ratio | 4.105 |
Price to Book Value | 3.984 |
Price to Free Cash Flow | 16.16 |
Earnings Yield | 3.29% |
Market Cap | 207.41B |
Operating PE Ratio | 23.30 |
Normalized PE Ratio | 30.43 |